Stripping Massage Technique and Post-isometric Relaxation

Combined Effects of Stripping Massage Technique and Post Isometric Relaxation on Pain, ROM and Functional Movement in Patients With Trapezius Myalgia

This randomized clinical trial investigates the synergistic effects of stripping massage and Post-Isometric Relaxation (PIR) on pain alleviation, ROM and functional movement improvement in individuals with Trapezius myalgia. A purposive sampling approach will select participants aged 18 and 50 years. A total of 44 patients will be taken, who will be randomly divided into two equal groups, each containing 22 patients. Group A will receive standard baseline management, supplemented with heating pad, active stretching, isometrics and ischemic compression, while Group B will receive the combined management (stripping massage + PIR) .

The study will assess pain intensity using NPRS, ROM using goniometer and neck disability or functional movement of neck using Neck Disability Index (NDI) at baseline and four weeks follow-up. Ethical approval and informed consent will ensure the study's integrity. The primary outcomes will focus on pain reduction and improved neck function, with secondary outcomes including trigger point severity and range of motion. Data analysis will utilize SPSS version 25. This study aims to provide valuable insights into the combined efficacy of stripping massage and PIR, ultimately informing evidence-based practice and enhancing patient outcomes in patients with trapezius myalgia.

Inclusion Criteria:

• Presenting with neck pain and stiffness
• Experiencing tightness in the upper trapezius muscle
• Having pain at rest, local twitch response or jump sign in upper trapezius
• Patients having functional limitations while performing certain activities of everyday living.

Exclusion Criteria:

• Patients with an NPRS score of 3 or less.
• Presence of structural abnormalities like torticollis or scoliosis.
• Presence of skin disease on the back.
• Having undergone upper limb surgery within the past year .
• Participation in another clinical trial.
• Severe psychiatric conditions that would impair participation or compliance